Premium
Budesonide — A New Steroid for Intranasal Use
Author(s) -
Warland A.,
Møller P.,
Lindqvist N.
Publication year - 1981
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1981.tb01849.x
Subject(s) - budesonide , nasal administration , placebo , medicine , incidence (geometry) , corticosteroid , nasal spray , nose , double blind , anesthesia , surgery , pharmacology , pathology , physics , alternative medicine , optics
Twenty‐nine patients with seasonal rhinitis completed a double‐blind study comparing budesonide nasal spray 200 μg b.i.d. with placebo. The patients were randomly assigned into two parallel groups. Symptoms were assessed over a treatment period of 3 weeks. There were statistically significant differences in favour of budesonide on all measurements. Side effects were mild and the incidence was low.